Michalski C, Kan B, Lavoie PM. Antifungal immunological defenses in newborns. Front Immunol. 2017;8:281. https://doi.org/10.3389/fimmu.2017.00281.
CAS PubMed PubMed Central Google Scholar
Cortese F, Scicchitano P, Gesualdo M, Filaninno A, De Giorgi E, Schettini F, et al. Early and late infections in newborns: where do we stand? A review. Pediatr Neonatol. 2016;57(4):265–73. https://doi.org/10.1016/j.pedneo.2015.09.007.
Bellmann R, Smuszkiewicz P. Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients. Infection. 2017;45(6):737–79. https://doi.org/10.1007/s15010-017-1042-z.
CAS PubMed PubMed Central Google Scholar
Fisher MC, Alastruey-Izquierdo A, Berman J, Bicanic T, Bignell EM, Bowyer P, et al. Tackling the emerging threat of antifungal resistance to human health. Nat Rev Microbiol. 2022;20(9):557–71. https://doi.org/10.1038/s41579-022-00720-1.
CAS PubMed PubMed Central Google Scholar
Jain A, Jain S, Rawat S. Emerging fungal infections among children: a review on its clinical manifestations, diagnosis, and prevention. J Pharm Bioallied Sci. 2010;2(4):314–20. https://doi.org/10.4103/0975-7406.72131.
PubMed PubMed Central Google Scholar
Stoll BJ, Hansen NI, Adams-Chapman I, Fanaroff AA, Hintz SR, Vohr B, National Institute of Child Health and Human Development Neonatal Research Network, et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics. 2002;110(2 Pt 1):285–91.
Benjamin DK Jr, Stoll BJ, Gantz MG, Walsh MC, Sánchez PJ, Das A, et al. Neonatal candidiasis: epidemiology, risk factors, and clinical judgment. Pediatrics. 2010;126(4):e865–73. https://doi.org/10.1542/peds.2009-3412.
Fridkin SK, Kaufman D, Edwards JR, Shetty S, Horan T. Changing incidence of Candida bloodstream infections among NICU patients in the United States: 1995–2004. Pediatrics. 2006;117(5):1680–7.
Cotten CM, Taylor S, Stoll B, Goldberg RN, Hansen NI, Sánchez PJ, et al. The association of third-generation cephalosporin use and invasive candidiasis in extremely low birth-weight infants. Pediatrics. 2006;118(2):717–22.
Clerihew L, Lamagni TL, Brocklehurst P, McGuire W. Invasive fungal infection in very low birthweight infants: National Prospective Surveillance Study. Arch Dis Child Fetal Neonatal Ed. 2006;91(3):F188–92. https://doi.org/10.1136/adc.2005.082024.
Saiman L, Ludington E, Pfaller M, Rangel-Frausto S, Wiblin T, Dawson J, et al. Risk factors for candidemia in neonatal intensive care unit patients. Pediatr Infect Dis J. 2000;19(4):319–24.
Darmstadt GL, Dinulos JG, Miller Z. Congenital cutaneous candidiasis: clinical presentation, pathogenesis, and management guidelines. Pediatrics. 2000;105(3):438–44.
Kaufman DA, Coggins SA, Zanelli SA, Weitkamp JH. Congenital cutaneous candidiasis: prompt systemic treatment is associated with improved outcomes in neonates. Clin Infect Dis. 2017;64(10):1387–95.
Schulz B, Welte T, Cornely OA. Neonatal and pediatric candidemia: results from population-based surveillance. J Pediatr Infect Dis Soc. 2018;7(3):e78-85. https://doi.org/10.1093/jpids/pix113.
Menezes FG, de Almeida JN. Neonatal invasive candidiasis in low- and middle-income countries. Microbiol Spectr. 2023;11(3):e01010-e1023. https://doi.org/10.1128/spectrum.01010-23.
Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;62(4):e1-50. https://doi.org/10.1093/cid/civ933.
Dermitzaki N, Baltogianni M, Tsekoura E, Giapros V. Invasive candida infections in neonatal intensive care units: risk factors and new insights in prevention. Pathogens. 2024;13(8):660. https://doi.org/10.3390/pathogens13080660.
PubMed PubMed Central Google Scholar
Kimura H, Mitsuto I, Taguchi R, Anzawa K, Mochizuki T. Primary cutaneous aspergillosis caused by Aspergillus tamarii in a premature infant with extremely low birthweight: a case report with short review. J Dermatol. 2018;45(5):622–5. https://doi.org/10.1111/1346-8138.14263.
Talento AF, Fitzgerald M, Redington B, O’Sullivan N, Fenelon L, Rogers TR. Prevention of healthcare-associated invasive aspergillosis during hospital construction/renovation works. J Hosp Infect. 2019;103:1–2.
Woodruff CA, Hebert AA. Neonatal primary cutaneous aspergillosis: case report and review of the literature. Pediatr Dermatol. 2002;19(5):439–44. https://doi.org/10.1046/j.1525-1470.2002.00203.x.
Groll AH, Jaeger G, Allendorf A, Herrmann G, Schloesser R, von Loewenich V. Invasive pulmonary aspergillosis in a critically ill neonate: case report and review of invasive aspergillosis during the first 3 months of life. Clin Infect Dis. 1998;27(3):437–52. https://doi.org/10.1086/514717.
Simpson CL, Boos MD, Castelo-Soccio L. A crusted papule in a premature neonate: cutaneous fungal infection. JAMA Pediatr. 2015;169(12):1173–4. https://doi.org/10.1001/jamapediatrics.2015.1359.
Rogdo B, Kahlert C, Diener PA, Micallef J. Primary cutaneous aspergillosis in a preterm neonate. BMJ Case Rep. 2014. https://doi.org/10.1136/bcr-2014-204752.
PubMed PubMed Central Google Scholar
Roncati L, Barbolini G, Fano RA, Rivasi F. Fatal Aspergillus flavus infection in a neonate. Fetal Pediatr Pathol. 2010;29(4):239–44. https://doi.org/10.3109/15513811003789636.
Phute SU, Bhakre JB. Aspergillus fumigatus meningitis in a preterm neonate. Indian Pediatr. 2011;47(11):980.
Guarner J, Brandt ME. Histopathologic diagnosis of fungal infections in the 21st century. Clin Microbiol Rev. 2011;24(2):247–80. https://doi.org/10.1128/CMR.00053-10.
PubMed PubMed Central Google Scholar
Redline RW, Dahms BB. Malassezia pulmonary vasculitis in an infant on long-term intralipid therapy. N Engl J Med. 1981;305(23):1395–8. https://doi.org/10.1056/NEJM198112033052307.
Zomorodain K, Mirhendi H, Tarazooie B, Kordbacheh P, Zeraati H, Nayeri F. Molecular analysis of Malassezia species isolated from hospitalized neonates. Pediatr Dermatol. 2008;25(3):312–6. https://doi.org/10.1111/j.1525-1470.2008.00673.x.
Marcon MJ, Powell DA. Epidemiology, diagnosis, and management of Malassezia furfur systemic infection. Diagn Microbiol Infect Dis. 1987;7(3):161–75. https://doi.org/10.1016/0732-8893(87)90001-0.
Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis. 2002;34(1):7–14. https://doi.org/10.1086/323335.
Honnavar P, Ghosh AK, Paul S, et al. Identification of Malassezia species by MALDI-TOF MS after expansion of database. Diagn Microbiol Infect Dis. 2018;92(2):118–23. https://doi.org/10.1016/j.diagmicrobio.2018.05.015.
Agarwal K, Sharma M, Singh S, Jain M. Antemortem diagnosis of gastrointestinal mucormycosis in neonates: report of two cases and review of literature. Indian J Pathol Microbiol. 2006;49(3):430–2.
Oh D, Notrica D. Primary cutaneous mucormycosis in infants and neonates: case report and review of the literature. J Pediatr Surg. 2002;37(11):1607–11. https://doi.org/10.1053/jpsu.2002.36193.
Diven SC, Angel CA, Hawkins HK, Rowen JL, Shattuck KE. Intestinal zygomycosis due to Absidia corymbifera mimicking necrotizing enterocolitis in a preterm neonate. J Perinatol. 2004;24(12):794–6. https://doi.org/10.1038/sj.jp.7211186.
Linder N, Keller N, Huri C, Kuint J, Goldshmidt-Reuven A, Barzilai A. Primary cutaneous mucormycosis in a premature infant: case report and review of the literature. Am J Perinatol. 1998;15(1):35–8. https://doi.org/10.1055/s-2007-993895.
White CB, Barcia PJ, Bass JW. Neonatal zygomycotic necrotizing cellulitis. Pediatrics. 1986;78(1):100–2.
Dennis JE, Rhodes KH, Cooney DR, Roberts GD. Nosocomial Rhizopus infection (zygomycosis) in children. J Pediatr. 1980;96(5):824–8. https://doi.org/10.1016/s0022-3476(80)80550-6.
Comments (0)